Provided by Tiger Trade Technology Pte. Ltd.

Diffusion Pharmaceuticals Inc

4.40
0.0000
Volume:- -
Turnover:1.67M
Market Cap:5.98M
PE:-0.46
High:4.40
Open:4.40
Low:4.40
Close:4.40
52wk High:11.70
52wk Low:4.14
Shares:1.36M
Float Shares:1.35M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.6195
EPS(LYR):-11.4705
ROE:-63.96%
ROA:-38.24%
PB:0.42
PE(LYR):-0.38

Loading ...

Company Profile

Company Name:
Diffusion Pharmaceuticals Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia.